24 February 2011
Last updated at 05:21 ET
The drugs watchdog said Avastin had 'no demonstrable benefit'
The drug Avastin should not be used to treat secondary breast cancers, the NHS drugs advisory body NICE says.
The National Institute for Health and Clinical Excellence, which issues guidance for NHS in England and Wales, said there was insufficient evidence that the drug
No comments:
Post a Comment